¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/25 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2023-03-22
Á¶È¸¼ö
163


¾È³çÇϼ¼¿ä.
À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù.
 
Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2023³â Immunity ¿¡ ÃâÆǵÈ
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity " ÀÔ´Ï´Ù.
 
DopamineÀº Áß¿äÇÑ neurotransmitter Áß¿¡ ÇϳªÀ̸ç,
¸é¿ª¼¼Æ÷ activity ¹× allergic imflammationÀ» Á¶Àý ÇÒ ¼ö ÀÖÀ½ÀÌ ¾Ë·ÁÁ®ÀÖ½À´Ï´Ù.
º» ³í¹®¿¡¼­´Â dopamine ó¸® ½Ã ILC2 response ¹× airway inflammationÀÌ °¨¼ÒÇÔÀ» È®ÀÎÇÏ¿´À¸¸ç,
´õ ³ª¾Æ°¡ dopaminÀÌ ILC2 OXPHOS pathway¸¦ ¾ïÁ¦ÇÔÀ» È®ÀÎÇÏ¿´½À´Ï´Ù.
µû¶ó¼­ º» ³í¹®¿¡¼­´Â dopamineÀÌ Ãµ½ÄÄ¡·áÁ¦·Î¼­ÀÇ °¡´É¼ºÀÌ ÀÖÀ½À» ½Ã»çÇÏ°í ÀÖ½À´Ï´Ù.
 
º» ³í¹®À» ¼±Á¤ÇÑ ÀÌÀ¯´Â
ILC2 °ü·Ã ¿¬±¸µ¿ÇâÀ» ÆľÇÇÏ°í,
ÇöÀç ÁøÇàÇÏ°í ÀÖ´Â ¿¬±¸¿¡ Âü°íÇÒ Á¡ÀÌ ¸¹±â¿¡ ¼±Á¤ÇÏ¿´½À´Ï´Ù.  
 
¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
 
°¨»çÇÕ´Ï´Ù.
Æò¿µÁø ¿Ã¸²

¹ßÇ¥³í¹® ¸µÅ©: https://www.cell.com/immunity/fulltext/S1074-7613(22)00675-6
 
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
3/25 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº2016³â nature communication¿¡ ÃâÆÇµÈ "Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation" ÀÔ´Ï´Ù. Saponin-based adjuvants (SBAs) ´Â protective cellular immunity ¸¦ À¯µµÇÏ..
ÀÌÀü±Û
3/18 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. µµºóÀÔ´Ï´Ù. À̹ø ¹ßÇ¥ ³í¹®Àº ¿ÃÇØ 2¿ù Science Immunology ¿¡ ÃâÆÇµÈ 'IL-21R signal reprogramming cooperates with CD40 and BCR signals to select and differentiate germinal center B cells' ÀÔ´Ï´Ù. GCBC Àº GC ÀÇ DZ, LZ À» ¼øȯÇϸç Tfh °ú interaction À» °ÅÃÄ ÃÖÁ¾ÀûÀ¸·Î plasma ..